MA H1107

Prohibits insurers and drug coverage plans from reimbursing 340B-covered entities or contract pharmacies at lower rates than non-340B pharmacies for the same drugs

Bars discriminatory terms including differential fees, chargebacks, clawbacks, dispensing fees, pharmacy network participation requirements, and audit frequency based on 340B status

Prohibits requiring claims to include 340B identifiers or modifiers, except for Medicaid claims

Prevents drug manufacturers and distributors from restricting 340B drug acquisition or delivery to contract pharmacies, or requiring data submissions as a condition of drug access

Protects patient choice by prohibiting entities from steering patients away from receiving drugs at 340B-covered entities or their contract pharmacies

Applies across multiple insurance chapters (32A, 175, 176A, 176B, 176G, 176I) and classifies manufacturer/distributor violations as unfair or deceptive practices under Chapter 93A